Establishment Labs (ESTA) Competitors

Establishment Labs (NASDAQ:ESTA) and Avanos Medical (NYSE:AVNS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, community ranking, dividends, earnings, institutional ownership and profitability.

Does the media prefer ESTA or AVNS?

In the previous week, Avanos Medical had 2 more articles in the media than Establishment Labs. MarketBeat recorded 3 mentions for Avanos Medical and 1 mentions for Establishment Labs. Avanos Medical's average media sentiment score of 1.59 beat Establishment Labs' score of 0.78 indicating that Avanos Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Avanos Medical	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do analysts recommend ESTA or AVNS?

Establishment Labs currently has a consensus price target of $95.20, suggesting a potential upside of 43.40%. Avanos Medical has a consensus price target of $30.25, suggesting a potential upside of 18.26%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts plainly believe Establishment Labs is more favorable than Avanos Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Avanos Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Is ESTA or AVNS more profitable?

Avanos Medical has a net margin of 5.34% compared to Establishment Labs' net margin of -47.84%. Avanos Medical's return on equity of 6.11% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-47.84%	-422.08%	-32.77%
Avanos Medical	5.34%	6.11%	4.43%

Which has more volatility and risk, ESTA or AVNS?

Establishment Labs has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. Comparatively, Avanos Medical has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500.

Which has stronger earnings & valuation, ESTA or AVNS?

Avanos Medical has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Avanos Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$161.70 million	10.57	-$75.21 million	-$3.31	-20.06
Avanos Medical	$820 million	1.46	$50.50 million	$0.92	27.80

Does the MarketBeat Community prefer ESTA or AVNS?

Establishment Labs received 22 more outperform votes than Avanos Medical when rated by MarketBeat users. Likewise, 60.23% of users gave Establishment Labs an outperform vote while only 56.64% of users gave Avanos Medical an outperform vote.

Company	Underperform	Outperform
Establishment Labs	Outperform Votes 103 60.23%	Underperform Votes 68 39.77%
Avanos Medical	Outperform Votes 81 56.64%	Underperform Votes 62 43.36%

Do insiders and institutionals have more ownership in ESTA or AVNS?

75.3% of Establishment Labs shares are owned by institutional investors. Comparatively, 92.1% of Avanos Medical shares are owned by institutional investors. 12.6% of Establishment Labs shares are owned by insiders. Comparatively, 2.9% of Avanos Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Avanos Medical beats Establishment Labs on 10 of the 18 factors compared between the two stocks.